About Readline

Readline is a bio-pharmaceutical high-tech company with a multidisciplinary application based on enzyme catalysis technology. It is the world's first company to use directed evolution of enzymes in the large-scale production of API such as peptides, carbohydrate, and nucleic acids on an all-green basis. These APIs are primarily used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers, and other applications.

Company Highlights
Year Founded

2017

icon-altEmployees

35

Location (HQ)

CHN

Since Last Funding

1 year 5 months

Monthly Website Visitors

4.3K

icon-altTotal Investment Amt

$58M

Last Funding Round

Series B

icon-altMoM Headcount Growth

6.04%

icon-altYoY Headcount Growth

16.61%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical Manufacturing

Pharmaceuticals

Biotechnology

Agriculture